Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia … (NCT02307994) | Clinical Trial Compass
UnknownPhase 4
Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH
China180 participantsStarted 2014-08
Plain-language summary
The purpose of this study is to determine whether uFSH is effective and safe in the treatment of male patients with severe oligospermia or azoospermia.
Who can participate
Age range25 Years – 35 Years
SexMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male subjects aged 20\~35.
* They accorded with diagnostic criteria of severe oligospermia or azoospermia.
* They had'nt been treated with drug which could improve sperm count and quality one month before observation,otherwise,they should have a elution for 1 month before the study.
Exclusion Criteria:
* Gram-positive bacteria ,Chlamydia trachomatis,Ureaplasmaurealyticum,or mycoplasma hominis were detected in their semen.
* Subjects addicted to drug,tobacco,or alcohol.
* Subjects had heat,chemicals,radioactive material,or toxic contact history within a year.
* Subjects were under treatment of gonadotropin,anabolic steroid,chemotherapeutic drugs,or nonsteroidal anti-inflammatory drugs .
* Subjects combined with cardiovascular, liver, kidney ,or hematopoietic system severe primary disease,or mental disease.
* Subjects were allergic or on uFSH allergy,or under the treatment of other drugs for infertility .
* Subjects did not meet the inclusion criteria, did not according to the prescribed medication, were unable to judge the efficacy ,had incomplete information, or affected the efficacy or safety judgment.
* Subjects were IHH patients